Product Wiki · Recalls · U.S. FDA — Device Enforcement

Recall Z-1352-2018 — Magstim Rapid Therapy System consisting of: Rapid Mainframe, Rapid Single Power Supply Unit , Rapid User Interface, Air Film Coil and Main Filters Product Usage For the treatment of major depressive disorders in adult patients who have failed to achieve satisfactory improvement from prior antidep

U.S. FDA — Device Enforcement · United Kingdom · 2017-09-28 · Class II

AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →

Agency: U.S. FDA — Device Enforcement
Recall identifier: Z-1352-2018
Date of alert: 2017-09-28
Country / jurisdiction: United Kingdom
Risk level: Class II
Risk type: recall
Brand: The Magstim Company Limited
Product category: device
Product type: Devices

Reported risk: Users manuals not supplied with 4800-00T US Rapid Therapy System

Primary source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.

Related